Applied Organometallic Chemistry | Cas: 100-54-9 was involved in experiment

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.SDS of cas: 100-54-9 This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Luo, Lan;Liu, Hongqiang;Zeng, Wei;Hu, Wenkang;Wang, Dawei published 《BTP-Rh@g-C3N4 as an efficient recyclable catalyst for dehydrogenation and borrowing hydrogen reactions》 in 2022. The article was appeared in 《Applied Organometallic Chemistry》. They have made some progress in their research.SDS of cas: 100-54-9 The article mentions the following:

Highly active catalysts play an important role in modern catalysis. A novel and efficient ligand benzotriazole-pyrimidine (BTP) and the corresponding rhodium composite on C3N4 were successfully synthesized. The resulting rhodium composite was fully characterized by SEM (SEM), transmission electron microscopy (TEM), x-ray diffraction (XRD), thermogravimetric anal. (TGA), and XPS. The obtained composite exhibited good catalytic activity and good recovery performance in the synthesis of quinoxaline from 2-aminobenzyl alc. and benzonitrile, and more than 20 quinoxalines were obtained in good yields. Addnl., it also showed that rhodium composite could achieved good catalytic performance in the synthesis of functionalized ketone through borrowing hydrogen strategy. And 3-Cyanopyridine (cas: 100-54-9) was used in the research process.

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.SDS of cas: 100-54-9 This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem